|
Back to:
Desloratadine
(Last updated December 2025)
Figure 1. The molecular diagram of Desloratadine.
CSP studies
| REFCODE | |
| Formula | C19 H19 N2 Cl1 |
| Common Name | Desloratadine |
| IUPAC Systematic Name | 8-chloro-6,11-dihydro-11-(4-piperdinylidene)- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine |
| Other Names | |
| CSD Refcodes | GEHXEX01, GEHXEX04, GEHXEX02 |
| |
| Search Identifier | |
| Scientist | Rui Guo |
| Date | December 2016 |
| Publication | Srirambhatla VK, Guo R, Dawson DM, Price SL, Florence AJ, Cryst Growth Des 2020, 20(3), 1800 |
| Energy model | |
| Study_ID | 10 |
| Programs | CrystalPredictor (2.1.01), CrystalOptimizer (2.4), DMACRYS (2.2.0.1) |
| Location on S Drive | CHEMISTRY_CPOSS\Desloratadine\CrystOpt |
| Potential Description | CrystalOptimizer with GDMA2.2(PBE0/6-31G(d,p)) + FIT |
| Intramolecular Description | PBE0/6-31G(d,p)) |
| pDFT structures | |
| Energy model | |
| Study_ID | 30 |
| Programs | Study_ID=10, DMACRYS (2.2.0.1) |
| Location on S Drive | CHEMISTRY_CPOSS\Desloratadine\PCM |
| Potential Description | GDMA2.2(PCMdielectric3(PBE0/6-31G(d,p))) + FIT |
| Intramolecular Description | PCMdielectric3(PBE0/6-31G(d,p) |
Figure 2. Lattice Energy Landscapes of Desloratadine. Energy models A1 and A2. Line chart comparing DFT+D energy models.
CSD structures (CSD version 6.01)
Table 1. Crystallographic information and experimental information of CSD entries for Desloratadine. Different polymorphs, as ascertained by structure matching of 20 molecule coordination sphere in Mercury, are coloured differently. Reference polymorphs are outlined in bold.
| REFCODE | Spacegroup | Z' | a / Å | b / Å | c / Å | α / ° | β / ° | γ / ° | density / g cm-3 | Form | R factor | T / K | Year | Comment / reference | REFCODE |
| GEHXEX | P21 | 1.0 | 6.9336 | 11.9980 | 9.46910 | 90.0 | 107.36500 | 90.0 | 1.3729 | polymorph I | 3.2 | at 100 K | 2006 | 10.1107/S0108270106012571 | GEHXEX |
| GEHXEX01 | P21 | 1.0 | 6.9522 | 12.006 | 9.48040 | 90.0 | 107.387 | 90.0 | 1.3669 | polymorph I | 4.21 | 80 K | 2020 | 10.1021/acs.cgd.9b01522 | GEHXEX01 |
| GEHXEX02 | P21 | 1.0 | 7.7534 | 12.1384 | 9.608 | 90.0 | 118.77999 | 90.0 | 1.3024 | polymorph III | 3.989 | 360 K | 2020 | 10.1021/acs.cgd.9b01522 | GEHXEX02 |
| GEHXEX03 | P21 | 1.0 | 7.061 | 12.0699 | 9.55900 | 90.0 | 108.2 | 90.0 | 1.3338 | polymorph I | 4.79 | 293 K | 2020 | 10.1021/acs.cgd.9b01522 | GEHXEX03 |
| GEHXEX04 | P21 | 2.0 | 14.818 | 12.223 | 9.631 | 90.0 | 113.25500 | 90.0 | 1.2881 | polymorph II | 6.569 | 335 K | 2020 | 10.1021/acs.cgd.9b01522 | GEHXEX04 |
The Word Document has some crystallization conditions.
Other Notes
On heating desloratadine, either as a single crystal, as a powder, in the DSC or in VT-Raman, two phase transformations occur. All the forms are enantiotropically related, and Forms I and III differ in the orientation of the 6-membered ring with respect to the benzodiazepine group. In Form II, half the molecules take each conformation (it is not disordered).
|